BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7795269)

  • 21. Multidrug resistance-associated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion.
    Barrand MA; Bagrij T; Neo SY
    Gen Pharmacol; 1997 May; 28(5):639-45. PubMed ID: 9184795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells.
    Ranjbar S; Khonkarn R; Moreno A; Baubichon-Cortay H; Miri R; Khoshneviszadeh M; Saso L; Edraki N; Falson P; Firuzi O
    Toxicol Appl Pharmacol; 2019 Jan; 362():136-149. PubMed ID: 30391378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.
    Watanabe T; Uchiyama N; Roninson IB; Cohen D; Atadja P
    Int J Oncol; 2000 Sep; 17(3):579-86. PubMed ID: 10938401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological characterization of LY335979: a potent cyclopropyldibenzosuberane modulator of P-glycoprotein.
    Starling JJ; Shepard RL; Cao J; Law KL; Norman BH; Kroin JS; Ehlhardt WJ; Baughman TM; Winter MA; Bell MG; Shih C; Gruber J; Elmquist WF; Dantzig AH
    Adv Enzyme Regul; 1997; 37():335-47. PubMed ID: 9381979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The multidrug resistance phenotype confers immunological resistance.
    Weisburg JH; Curcio M; Caron PC; Raghu G; Mechetner EB; Roepe PD; Scheinberg DA
    J Exp Med; 1996 Jun; 183(6):2699-704. PubMed ID: 8676093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between multidrug resistant gene expression and multidrug resistant-reversing effect of MS-209 in various tumor cells.
    Baba M; Nakanishi O; Sato W; Saito A; Miyama Y; Yano O; Shimada S; Fukazawa N; Naito M; Tsuruo T
    Cancer Chemother Pharmacol; 1995; 36(5):361-7. PubMed ID: 7634376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR).
    Teodori E; Dei S; Martelli C; Scapecchi S
    Curr Top Med Chem; 2010; 10(17):1715-31. PubMed ID: 20645921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by AV200, a new ardeemin derivative.
    Méndez-Vidal C; Quesada AR
    Cancer Lett; 1998 Oct; 132(1-2):45-50. PubMed ID: 10397452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regression of established tumors expressing P-glycoprotein by combinations of adriamycin, cyclosporin derivatives, and MRK-16 antibodies.
    Watanabe T; Naito M; Kokubu N; Tsuruo T
    J Natl Cancer Inst; 1997 Apr; 89(7):512-8. PubMed ID: 9086008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833.
    Jiang XR; Kelsey SM; Wu YL; Newland AC
    Br J Haematol; 1995 Jun; 90(2):375-83. PubMed ID: 7794760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibody MRK16 reverses the multidrug resistance of multidrug-resistant transgenic mice.
    Mickisch GH; Pai LH; Gottesman MM; Pastan I
    Cancer Res; 1992 Aug; 52(16):4427-32. PubMed ID: 1353705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes.
    Yano S; Sone S; Nishioka Y; Naito M; Tsuruo T; Ogura T
    Jpn J Cancer Res; 1994 Feb; 85(2):194-203. PubMed ID: 7511575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3,5-dibenzoyl-1,4-dihydropyridines: synthesis and MDR reversal in tumor cells.
    Kawase M; Shah A; Gaveriya H; Motohashi N; Sakagami H; Varga A; Molnár J
    Bioorg Med Chem; 2002 Apr; 10(4):1051-5. PubMed ID: 11836114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diverse effects of P-glycoprotein inhibitory agents on human leukemia cells expressing the multidrug resistance protein (MRP).
    Lehne G; Mørkrid L; den Boer M; Rugstad HE
    Int J Clin Pharmacol Ther; 2000 Apr; 38(4):187-95. PubMed ID: 10783828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
    Pérez-Tomás R
    Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
    Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
    Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and function of multidrug resistance P-glycoprotein in a cultured natural killer cell-rich population revealed by MRK16 monoclonal antibody and AHC-52.
    Kobayashi Y; Yamashiro T; Nagatake H; Yamamoto T; Watanabe N; Tanaka H; Shigenobu K; Tsuruo T
    Biochem Pharmacol; 1994 Oct; 48(8):1641-6. PubMed ID: 7980629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New flow cytometric method for detection of minimally expressed multidrug resistance P-glycoprotein on normal and acute leukemia cells using biotinylated MRK16 and streptavidin-RED670 conjugate.
    Takeshita A; Shinjo K; Ohnishi K; Ohno R
    Jpn J Cancer Res; 1995 Jun; 86(6):607-15. PubMed ID: 7622426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular levels of two cyclosporin derivatives valspodar (PSC 833) and cyclosporin a closely associated with multidrug resistance-modulating activity in sublines of human colorectal adenocarcinoma HCT-15.
    Uchiyama-Kokubu N; Watanabe T; Cohen D
    Jpn J Cancer Res; 2001 Oct; 92(10):1116-26. PubMed ID: 11676863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.